These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 27887590)

  • 1. Comparing the adverse clinical outcomes in patients with non-insulin treated type 2 diabetes mellitus and patients without type 2 diabetes mellitus following percutaneous coronary intervention: a systematic review and meta-analysis.
    Li N; Yang YG; Chen MH
    BMC Cardiovasc Disord; 2016 Nov; 16(1):238. PubMed ID: 27887590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing the Clinical Outcomes Between Insulin-treated and Non-insulin-treated Patients With Type 2 Diabetes Mellitus After Coronary Artery Bypass Surgery: A Systematic Review and Meta-analysis.
    Munnee K; Bundhun PK; Quan H; Tang Z
    Medicine (Baltimore); 2016 Mar; 95(10):e3006. PubMed ID: 26962814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-hospital, short-term and long-term adverse clinical outcomes observed in patients with type 2 diabetes mellitus vs non-diabetes mellitus following percutaneous coronary intervention: A meta-analysis including 139,774 patients.
    Zhuo X; Zhang C; Feng J; Ouyang S; Niu P; Dai Z
    Medicine (Baltimore); 2019 Feb; 98(8):e14669. PubMed ID: 30813214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should a prolonged duration of dual anti-platelet therapy be recommended to patients with diabetes mellitus following percutaneous coronary intervention? A systematic review and meta-analysis of 15 studies.
    Bundhun PK; Yanamala CM; Huang F
    BMC Cardiovasc Disord; 2016 Aug; 16(1):161. PubMed ID: 27577530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse cardiovascular outcomes between insulin-treated and non-insulin treated diabetic patients after percutaneous coronary intervention: a systematic review and meta-analysis.
    Bundhun PK; Li N; Chen MH
    Cardiovasc Diabetol; 2015 Oct; 14():135. PubMed ID: 26446829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary artery bypass surgery compared with percutaneous coronary interventions in patients with insulin-treated type 2 diabetes mellitus: a systematic review and meta-analysis of 6 randomized controlled trials.
    Bundhun PK; Wu ZJ; Chen MH
    Cardiovasc Diabetol; 2016 Jan; 15():2. PubMed ID: 26739589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-Term Versus Long-Term Adverse Cardiovascular Outcomes Post Percutaneous Coronary Intervention in Patients with Insulin-Treated Type 2 Diabetes Mellitus: A Simple Meta-Analysis.
    Lu H; Tang B; Zhou Y; Xu C; Bundhun PK; Tang Z; Bao H
    Diabetes Ther; 2019 Aug; 10(4):1487-1497. PubMed ID: 31256352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short- and long-term cardiovascular outcomes in insulin-treated versus non-insulin-treated diabetes mellitus patients after percutaneous coronary intervention: A systematic review and meta-analysis.
    Hassan W; Saquib J; Khatri M; Kazmi SK; Kotak S; Hassan H; Ahmed J
    Indian Heart J; 2022; 74(1):13-21. PubMed ID: 34906538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early (≤ 30 Days), Late (31-360 Days) and Very Late (> 360 Days) Stent Thrombosis in Patients with Insulin-Treated versus Non-Insulin-Treated Type 2 Diabetes Mellitus: A Meta-Analysis.
    Chen W; Wu Y; Hu Y
    Diabetes Ther; 2018 Jun; 9(3):1113-1124. PubMed ID: 29644619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing the Clinical Outcomes between Drug Eluting Stents and Bare Metal Stents in Patients with Insulin-Treated Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of 10 Randomized Controlled Trials.
    Bundhun PK; Bhurtu A; Soogund MZ; Long MY
    PLoS One; 2016; 11(4):e0154064. PubMed ID: 27111304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contemporary Outcomes of Coronary Artery Bypass Grafting Among Patients With Insulin-Treated and Non-Insulin-Treated Diabetes.
    Li Z; Amsterdam EA; Young JN; Hoegh H; Armstrong EJ
    Ann Thorac Surg; 2015 Dec; 100(6):2262-9. PubMed ID: 26319487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary artery bypass grafting versus percutaneous coronary intervention in patients with noninsulin treated type 2 diabetes mellitus: A meta-analysis of randomized controlled trials.
    Wang Y; Wen M; Zhou J; Chen Y; Zhang Q
    Diabetes Metab Res Rev; 2018 Jan; 34(1):. PubMed ID: 28921837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse clinical outcomes associated with a low dose and a high dose of aspirin following percutaneous coronary intervention: a systematic review and meta-analysis.
    Bundhun PK; Janoo G; Teeluck AR; Huang WQ
    BMC Cardiovasc Disord; 2016 Sep; 16(1):169. PubMed ID: 27590185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing the adverse clinical outcomes associated with fraction flow reserve-guided versus angiography-guided percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials.
    Bundhun PK; Yanamala CM; Huang F
    BMC Cardiovasc Disord; 2016 Dec; 16(1):249. PubMed ID: 27912739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous coronary intervention in insulin-treated diabetic patients: A meta-analysis.
    Ge Y; He D; Shao Y; Wang L; Yan W
    Ann Noninvasive Electrocardiol; 2022 Sep; 27(5):e12953. PubMed ID: 35467783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality after percutaneous coronary revascularization: Prior cardiovascular risk factor control and improved outcomes in patients with diabetes mellitus.
    Noman A; Balasubramaniam K; Alhous MHA; Lee K; Jesudason P; Rashid M; Mamas MA; Zaman AG
    Catheter Cardiovasc Interv; 2017 Jun; 89(7):1195-1204. PubMed ID: 28029209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing the effectiveness and safety between triple antiplatelet therapy and dual antiplatelet therapy in type 2 diabetes mellitus patients after coronary stents implantation: a systematic review and meta-analysis of randomized controlled trials.
    Bundhun PK; Qin T; Chen MH
    BMC Cardiovasc Disord; 2015 Oct; 15():118. PubMed ID: 26450578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One year clinical outcomes in patients with insulin-treated diabetes mellitus and non-insulin-treated diabetes mellitus compared to non-diabetics after deployment of the bio-engineered COMBO stent.
    Kalkman DN; Woudstra P; den Heijer P; Menown IB; Erglis A; Suryapranata H; Arkenbout KE; Iñiguez A; van 't Hof AW; Muller P; Tijssen JG; de Winter RJ
    Int J Cardiol; 2017 Jan; 226():60-64. PubMed ID: 27788391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term mortality after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction in patients with insulin-treated versus non-insulin-treated diabetes mellitus.
    Hoebers LP; Claessen BE; Woudstra P; DeVries JH; Wykrzykowska JJ; Vis MM; Baan J; Koch KT; Tijssen JG; de Winter RJ; Piek JJ; Henriques JP
    EuroIntervention; 2014 May; 10(1):90-6. PubMed ID: 24832639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are women with type 2 diabetes mellitus more susceptible to cardiovascular complications following coronary angioplasty?: a meta-analysis.
    Bundhun PK; Pursun M; Huang F
    BMC Cardiovasc Disord; 2017 Jul; 17(1):207. PubMed ID: 28750607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.